Concepedia

K. Lea Sewell

KL

16

Publications

2.1K

Citations

14

H-Index

1989

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Ionis Pharmaceuticals (United States)

Pfizer (United States)

Schlosspark-Klinik

K. Lea Sewell is an author at Beth Israel Deaconess Medical Center specializing in medicine, rheumatology, and psoriatic arthritis.

Top concepts

Publications per year

1989–2018

16

Publications

16

Effects of Oral Administration of Type II Collagen on Rheumatoid Arthritis

David E. Trentham, Roselynn Dynesius‐Trentham, E. John Orav et al. · Science · 1993 · 630 citations

, , +18

Risedronate therapy prevents corticosteroid-induced bone loss : A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

Stanley Cohen, Robert M. Levy, Michael Keller et al. · Arthritis & Rheumatism · 1999 · 615 citations

Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria

Sharon G. Adler, Sherwyn Schwartz, Mark E. Williams et al. · Clinical Journal of the American Society of Nephrology · 2010 · 197 citations · Full text

Phase I Trial of ISIS 104838, a 2′-Methoxyethyl Modified Antisense Oligonucleotide Targeting Tumor Necrosis Factor-α

K. Lea Sewell, Richard S. Geary, Brenda F. Baker et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 120 citations

Suppression of collagen‐induced arthritis through adenovirus‐mediated transfer of a modified tumor necrosis factor α receptor gene

Christine Le, A. Graham Nicolson, Alejandro Morales et al. · Arthritis & Rheumatism · 1997 · 101 citations

Rows per page

1–5 of 16